RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 154 filers reported holding RA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 7.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,301,000 | -9.3% | 55,000 | -79.6% | 0.94% | +301.3% |
| Q1 2018 | $1,434,000 | +37.4% | 270,000 | +277.6% | 0.23% | +25.1% |
| Q3 2017 | $1,044,000 | -85.1% | 71,500 | -80.9% | 0.19% | -90.5% |
| Q2 2017 | $7,000,000 | +32.6% | 373,507 | +50.6% | 1.96% | +56.6% |
| Q1 2017 | $5,279,000 | -8.0% | 247,956 | -34.4% | 1.25% | -41.4% |
| Q4 2016 | $5,740,000 | – | 377,909 | – | 2.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,031,562 | $17,268,000 | 2.42% |
| NEA Management Company, LLC | 3,493,636 | $29,696,000 | 1.23% |
| VHCP Management II, LLC | 544,612 | $4,629,000 | 1.11% |
| RA Capital Management | 1,351,808 | $11,490,000 | 0.96% |
| Rock Springs Capital Management LP | 600,000 | $5,100,000 | 0.23% |
| Rhenman & Partners Asset Management AB | 108,451 | $922,000 | 0.12% |
| Tekla Capital Management LLC | 356,237 | $3,028,000 | 0.12% |
| ELLINGTON MANAGEMENT GROUP LLC | 34,900 | $297,000 | 0.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 79,150 | $673,000 | 0.03% |
| Candriam S.C.A. | 151,000 | $1,284,000 | 0.02% |